These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 24366688

  • 1. Promoter methylation status of MGMT, hMSH2, and hMLH1 and its relationship to corresponding protein expression and TP53 mutations in human esophageal squamous cell carcinoma.
    Su Y, Yin L, Liu R, Sheng J, Yang M, Wang Y, Pan E, Guo W, Pu Y, Zhang J, Liang G.
    Med Oncol; 2014 Feb; 31(2):784. PubMed ID: 24366688
    [Abstract] [Full Text] [Related]

  • 2. Aberrant methylation of different DNA repair genes demonstrates distinct prognostic value for esophageal cancer.
    Ling ZQ, Li P, Ge MH, Hu FJ, Fang XH, Dong ZM, Mao WM.
    Dig Dis Sci; 2011 Oct; 56(10):2992-3004. PubMed ID: 21674174
    [Abstract] [Full Text] [Related]

  • 3. Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence.
    Lee KH, Lee JS, Nam JH, Choi C, Lee MC, Park CS, Juhng SW, Lee JH.
    Langenbecks Arch Surg; 2011 Oct; 396(7):1017-26. PubMed ID: 21706233
    [Abstract] [Full Text] [Related]

  • 4. Protein expression and methylation of DNA repair genes hMLH1, hMSH2, MGMT and BRCA1 and their correlation with clinicopathological parameters and prognosis in basal-like breast cancer.
    Alkam Y, Mitomi H, Nakai K, Himuro T, Saito T, Takahashi M, Arakawa A, Yao T, Saito M.
    Histopathology; 2013 Nov; 63(5):713-25. PubMed ID: 24004112
    [Abstract] [Full Text] [Related]

  • 5. Aberrant DNA methylation of P16, MGMT, hMLH1 and hMSH2 genes in combination with the MTHFR C677T genetic polymorphism in gastric cancer.
    Xiong HL, Liu XQ, Sun AH, He Y, Li J, Xia Y.
    Asian Pac J Cancer Prev; 2013 Nov; 14(5):3139-42. PubMed ID: 23803092
    [Abstract] [Full Text] [Related]

  • 6. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
    Koutsimpelas D, Pongsapich W, Heinrich U, Mann S, Mann WJ, Brieger J.
    Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
    [Abstract] [Full Text] [Related]

  • 7. Promoter methylation of the hMLH1 gene and protein expression of human mutL homolog 1 and human mutS homolog 2 in resected esophageal squamous cell carcinoma.
    Tzao C, Hsu HS, Sun GH, Lai HL, Wang YC, Tung HJ, Yu CP, Cheng YL, Lee SC.
    J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1371. PubMed ID: 16256791
    [Abstract] [Full Text] [Related]

  • 8. Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism in esophageal squamous cell carcinoma.
    Wang J, Sasco AJ, Fu C, Xue H, Guo G, Hua Z, Zhou Q, Jiang Q, Xu B.
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):118-25. PubMed ID: 18199718
    [Abstract] [Full Text] [Related]

  • 9. Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism and folate intake in esophageal squamous cell carcinoma.
    Chen J, Huang ZJ, Duan YQ, Xiao XR, Jiang JQ, Zhang R.
    Asian Pac J Cancer Prev; 2012 Jan; 13(10):5303-6. PubMed ID: 23244153
    [Abstract] [Full Text] [Related]

  • 10. Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype.
    Sengupta S, Chakrabarti S, Roy A, Panda CK, Roychoudhury S.
    Cancer; 2007 Feb 15; 109(4):703-12. PubMed ID: 17219447
    [Abstract] [Full Text] [Related]

  • 11. Promoter hypermethylation of mismatch repair genes, hMLH1 and hMSH2 in oral squamous cell carcinoma.
    Czerninski R, Krichevsky S, Ashhab Y, Gazit D, Patel V, Ben-Yehuda D.
    Oral Dis; 2009 Apr 15; 15(3):206-13. PubMed ID: 19207881
    [Abstract] [Full Text] [Related]

  • 12. Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma.
    Suehiro Y, Wong CW, Chirieac LR, Kondo Y, Shen L, Webb CR, Chan YW, Chan AS, Chan TL, Wu TT, Rashid A, Hamanaka Y, Hinoda Y, Shannon RL, Wang X, Morris J, Issa JP, Yuen ST, Leung SY, Hamilton SR.
    Clin Cancer Res; 2008 May 01; 14(9):2560-9. PubMed ID: 18451217
    [Abstract] [Full Text] [Related]

  • 13. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z, Zhang H, Yang J, Hao T, Li S.
    Cell Biol Int; 2012 May 01; 36(5):427-32. PubMed ID: 21864295
    [Abstract] [Full Text] [Related]

  • 14. Clinical implications of mismatched repair gene promoter methylation in pancreatic cancer.
    Li M, Zhao ZW.
    Med Oncol; 2012 Jun 01; 29(2):970-6. PubMed ID: 21660619
    [Abstract] [Full Text] [Related]

  • 15. Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas.
    Psofaki V, Kalogera C, Tzambouras N, Stephanou D, Tsianos E, Seferiadis K, Kolios G.
    World J Gastroenterol; 2010 Jul 28; 16(28):3553-60. PubMed ID: 20653064
    [Abstract] [Full Text] [Related]

  • 16. Microsatellite mutations of transforming growth factor-beta receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation.
    Scott S, Kimura T, Ichinohasama R, Bergen S, Magliocco A, Reimer C, Kerviche A, Sheridan D, DeCoteau JF.
    Leuk Res; 2003 Jan 28; 27(1):23-34. PubMed ID: 12479849
    [Abstract] [Full Text] [Related]

  • 17. MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events.
    de Vogel S, Weijenberg MP, Herman JG, Wouters KA, de Goeij AF, van den Brandt PA, de Bruïne AP, van Engeland M.
    Ann Oncol; 2009 Jul 28; 20(7):1216-22. PubMed ID: 19164452
    [Abstract] [Full Text] [Related]

  • 18. Mismatch repair gene promoter methylation and expression in hydatidiform moles.
    Chen H, Ye D, Xie X, Lu W, Zhu C, Chen X.
    Arch Gynecol Obstet; 2005 Jun 28; 272(1):35-9. PubMed ID: 15338238
    [Abstract] [Full Text] [Related]

  • 19. Reduced expression of human DNA repair genes in esophageal squamous-cell carcinoma in china.
    Liu R, Yin LH, Pu YP.
    J Toxicol Environ Health A; 2007 Jun 28; 70(11):956-63. PubMed ID: 17479411
    [Abstract] [Full Text] [Related]

  • 20. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status.
    Wu JY, Wang J, Lai JC, Cheng YW, Yeh KT, Wu TC, Chen CY, Lee H.
    Ann Surg Oncol; 2008 Nov 28; 15(11):3272-7. PubMed ID: 18712569
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.